Competitive Intelligence

Atos: Services Capabilities for HCP, 2026

This Atos Competitive Intelligence Profile is for healthcare provider executives and sourcing leaders evaluating partners for sovereign AI and hospital-grade platforms that engineer outcomes across the quadruple aim of care.

Positioning chart titled HFS Horizons: HCP Service Providers, 2026, organized as three stacked horizontal bands. The left vertical axis, Innovation Scope, rises from Functional at the bottom, to Enterprise in the middle, to Network at the top. The right vertical axis, Value Aspiration, rises from Cost plus Experience at the bottom, to Experience plus Health in the middle, to Health plus Equity at the top. The bottom band is Horizon 1, Disruptors, aligned to the Functional and Cost plus Experience level. The middle band is Horizon 2, Enterprise Innovators, aligned to the Enterprise and Experience plus Health level. The top band is Horizon 3, Market Leaders, aligned to the Network and Health plus Equity level. Atos is placed in the middle band as a Horizon 2 Enterprise Innovator. The Horizon 2 Enterprise Innovators cohort also includes Capgemini, Carelon, CitiusTech, Ensemble Health Partners, EXL, Firstsource, Genpact, Guidehouse, IBM, Innova Solutions, Inovalon, MEDITECH, NTT DATA, Omega Healthcare, Oracle Cerner, Publicis Sapient, PwC, R1, SoftServe, Sutherland, UST, Virtusa, and Wipro. The Horizon 3 Market Leaders include Accenture, Cognizant, Deloitte, Epic, Evernorth, EY, HCLTech, Hitachi Digital Services, KPMG, Kyndryl, Optum, Sagility, and Tata Consultancy Services. The Horizon 1 Disruptors include AKKODiS, Coforge, DXC Technology, Emids, EPAM, Hexaware, HTC Global Services, LTM, Persistent, Smarter Technologies, Sonata, and Tech Mahindra. All providers within a Horizon are listed alphabetically and are not ranked against each other. The study assessed 50 healthcare providers in total. Source: HFS Research, 2026.

Note: All service providers within a Horizon are listed alphabetically
Source: HFS Research, 2026

Key facts about Atos’ HCP services capabilities

Panel layout titled Key facts about Atos' HCP services capabilities, divided into five boxes plus a gauge. Relevant M&A and partnerships box: no recent acquisitions are listed for 2022 to 2025. Listed partnerships are Google Cloud, Microsoft, AWS, Oracle, SAP, ServiceNow, IBM, Salesforce, EY, UiPath, Oracle Cerner, HealthEdge, Siemens Healthineers, Philips, Veradigm, Medidata, Lifemed, Visionable, Big Picture Medical, Teladoc Health, and COPE Health Solutions. Key clients box: number of clients 240, with named key clients not disclosed. Global operations and resources box: headcount of 1,000 HLS practitioners, with 36 offices including 10 global delivery centers across North America, Latin America, Europe, the UK, Japan, APAC, and the Middle East. Flagship internal IP box lists the Atos Polaris AI Suite, a proprietary AI platform for AI-augmented engineering, frictionless ops, and cloud migration; the Healthcare Data and Analytics Platform (H-DAP), a unified platform spanning EHR, imaging, clinical notes, IoT and streaming, and CRM data with GenAI apps and pre-built clinical AI and ML models; the Healthcare Industry Operating System and Digital Hospital Blueprint, a full-stack provider framework spanning Systems of Records, Digital Health Enterprise, and Digital Health Solutions; One Source Enterprise (OSE), an omnichannel patient access platform offering a 360-degree consumer view; and the COPE, Connecting Overdose Prevention Efforts, platform for public reporting and outreach organization coordination. A sustainability meter is shown as a semicircular gauge marked Low, Medium, and High, with the needle pointing into the upper-middle range toward Medium. Source: HFS Research, 2026.

Source: HFS Research, 2026

Atos’ performance in the study and HFS’ views of its strengths and development opportunities for HCP services capabilities

Slide titled Atos' performance in the study and HFS' views of its strengths and development opportunities for HCP services capabilities. On the left, a three-step Horizon ladder graphic highlights Horizon 2 Enterprise Innovator in the middle, where Atos sits, below Horizon 3 Market Leader and above Horizon 1 Disruptor. On the right, two lists. The Strengths list covers seven areas: value proposition, a hospital-grade technology and operations provider offering sovereign AI, the Digital Hospital Blueprint, and solutions anchored in the quadruple aim of care; capabilities across most of the provider value chain spanning patient consultation, acute care, post-acute care, patient services, and RCM; go-to-market that targets US health systems, the NHS, large integrated delivery networks, and Medicare administrative organizations via the Sovereign-by-Cyber-by-AI flywheel, consulting-led Digital Hospital Blueprint engagements, and outcome-based commercials; outcomes including cost reduction through AI-led denial prediction and revenue cycle automation, improved clinician experience through throughput optimization and intelligent bed management, advanced health outcomes through proactive screening outreach, and equity addressed by expanding overdose prevention coordination for underserved communities; innovation through multi-modal agentic AI developed with academic medical centers, prioritizing sovereign and HIPAA-grade deployment for clinical environments; customer perception, recognized for mission-critical delivery heritage, regulatory and sovereignty depth, and willingness to commit to outcome-based commercial structures; and partner perception, valued by hyperscaler and data platform partners for engineering execution depth, dependable joint delivery on data and AI workloads, and willingness to co-build agentic AI solutions. The Development opportunities list covers four areas: value proposition, where leading with clinical and provider operational outcomes rather than engineering and platform-delivery positioning would help; outcomes, where quantifying clinical outcomes and health-equity impact with named client attribution is becoming table stakes and must be a priority; customer, where elevating client relationships and showcasing outcomes through public-domain case studies is the opportunity; and partner, where diversifying with clinical AI startups and academic medical center research alliances would deepen value creation beyond the platform-vendor and hyperscaler core. Source: HFS Research, 2026.

Source: HFS Research, 2026

To read the complete report, click the download button below.

Sign in to view or download this research.

Login

Register

Insight. Inspiration. Impact.

Register now for immediate access of HFS' research, data and forward looking trends.

Get Started

Authors

Related

Download Research

    Sign In

    Sign up for a free
    research account

    With the exception of our Horizons reports, most of our research is available for free on our website. Sign up for a free account and start realizing the power of insights now.

    Digests/Newsletters: Overviews of the latest news, insight, and research by HFS.

    HFS Events: Exclusive invitations to HFS webinars, roundtables, and summits, bringing together key industry stakeholders focused on major innovations impacting business operations.

    By registering you agree to our privacy policy.

    I hereby consent that HFS Research can process my personal data.

    Premium Access

    Our premium subscription gives enterprise clients access to our complete library of proprietary research, direct access to our industry analysts, and other benefits.

    Contact us at [email protected] for more information on premium access.

    Help

    If you are looking for help getting in touch with someone from HFS, please click the chat button to the bottom right of your screen to start a conversation with a member of our team.

    [email protected]

      Contact Ask HFS AI Support